Compile Data Set for Download or QSAR
maximum 50k data
Found 180 with Last Name = 'bowsher' and Initial = 'm'
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50:  2.85E+3nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of midazolam as substrate preincubated for 30 mins in presence of NADPH follo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50:  3.02E+3nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of testosterone as substrate preincubated for 30 mins in presence of NADPH fo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50:  1.64E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of midazolam as substrate preincubated for 30 mins in presence of NADPH follo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50: >3.30E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of testosterone as substrate preincubated for 30 mins in presence of NADPH fo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of midazolam as substrate preincubated for 0 mins in presence of NADPH follow...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of testosterone as substrate preincubated for 0 mins in presence of NADPH fol...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of testosterone as substrate preincubated for 0 mins in presence of NADPH fol...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb Research And Early Development

Curated by ChEMBL
LigandPNGBDBM50565837(CHEMBL4787795)
Affinity DataIC50: >4.00E+4nMAssay Description:Inhibition of human CYP3A4 in human pooled liver microsomes in presence of midazolam as substrate preincubated for 0 mins in presence of NADPH follow...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229525(US9334279, 1001)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229525(US9334279, 1001)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229526(US9334279, 1002)
Affinity DataEC50:  59nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229526(US9334279, 1002)
Affinity DataEC50:  11.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229527(US9334279, 1003)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229527(US9334279, 1003)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229528(US9334279, 1004)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229528(US9334279, 1004)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229529(US9334279, 1005)
Affinity DataEC50:  1.48nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229529(US9334279, 1005)
Affinity DataEC50:  1.71nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229530(US9334279, 1006)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229530(US9334279, 1006)
Affinity DataEC50:  20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229531(US9334279, 1007)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229531(US9334279, 1007)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229532(US9334279, 1008)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229532(US9334279, 1008)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229533(US9334279, 1009)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229533(US9334279, 1009)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229534(US9334279, 1010)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229534(US9334279, 1010)
Affinity DataEC50:  20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229535(US9334279, 1011)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229535(US9334279, 1011)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229536(US9334279, 1012)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229536(US9334279, 1012)
Affinity DataEC50:  20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229537(US9334279, 1013)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229537(US9334279, 1013)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229538(US9334279, 1014)
Affinity DataEC50:  197nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229538(US9334279, 1014)
Affinity DataEC50:  20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229539(US9334279, 1015)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229539(US9334279, 1015)
Affinity DataEC50:  20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229540(US9334279, 1016)
Affinity DataEC50:  197nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229540(US9334279, 1016)
Affinity DataEC50:  197nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229541(US9334279, 1017)
Affinity DataEC50:  0.950nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229541(US9334279, 1017)
Affinity DataEC50:  0.820nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229542(US9334279, 1018)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229542(US9334279, 1018)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229543(US9334279, 1019)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229543(US9334279, 1019)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229544(US9334279, 1020)
Affinity DataEC50:  20nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229544(US9334279, 1020)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1711](Hepatitis C virus genotype 1a (strain H77) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229545(US9334279, 1021)
Affinity DataEC50:  3nMT: 2°CAssay Description:HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1028-1200,1251-1711](Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM229545(US9334279, 1021)
Affinity DataEC50:  0.75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 180 total ) | Next | Last >>
Jump to: